APOE4 Allele, Sex, and Dementia Risk in Parkinson’s Disease: Lessons From a Longitudinal Cohort

1. Tsuang, D, Leverenz, JB, Lopez, OL, et al. APOE ε4 increases risk for dementia in pure synucleinopathies. JAMA neurology. 2013;70(2):223-228.
Google Scholar | Crossref | Medline | ISI2. Samat, NA, Abdul Murad, NA, Mohamad, K, Abdul Razak, MR, Mohamed Ibrahim, N. Apolipoprotein Eε4: A biomarker for executive dysfunction among parkinson's disease patients with mild cognitive impairment. Front Neurosci. 2017;11:712.
Google Scholar | Crossref | Medline3. Liu, G, Peng, J, Liao, Z, et al. Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease. Nature. 2021;53(6):787-793.
Google Scholar4. Shahid, M, Kim, J, Leaver, K, et al. An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 allele. Neurobiol Dis. 2019;127:278-286.
Google Scholar | Crossref | Medline5. Mengel, D, Dams, J, Ziemek, J, et al. Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease. Parkinsonism & related disorders. 2016;29:112-116.
Google Scholar | Crossref | Medline6. Cholerton, B, Johnson, CO, Fish, B, et al. Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease. Parkinsonism & related disorders. 2018;50:29-36.
Google Scholar | Crossref | Medline7. Cereda, E, Cilia, R, Klersy, C, et al. Dementia in Parkinson's disease: Is male gender a risk factor? Parkinsonism & related disorders. 2016;26:67-72.
Google Scholar | Crossref | Medline8. Arnold, M, Nho, K, Kueider-Paisley, A, et al. Sex and APOE ε4 genotype modify the Alzheimer's disease serum metabolome. Nat Commun 2020;11(1):1148.
Google Scholar | Crossref | Medline9. Beekly, DL, Ramos, EM, Lee, WW, et al. The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set. Alzheimer disease and associated disorders. 2007;21(3):249-258.
Google Scholar | Crossref | Medline | ISI10. Weintraub, S, Salmon, D, Mercaldo, N, et al. The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery. Alzheimer disease and associated disorders. 2009;23(2):91-101.
Google Scholar | Crossref | Medline | ISI11. Mata, IF, Leverenz, JB, Weintraub, D, et al. APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease. JAMA neurology. 2014;71(11):1405-1412.
Google Scholar | Crossref | Medline12. Pankratz, N, Byder, L, Halter, C, et al. Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia. Movement disorders: Official Journal of the Movement Disorder Society. 2006;21(1):45-49.
Google Scholar | Crossref | Medline13. Huang, X, Chen, P, Kaufer, DI, Tröster, AI, Poole, C. Apolipoprotein E and dementia in Parkinson disease: a meta-analysis. Archives of neurology. 2006;63(2):189-193.
Google Scholar | Crossref | Medline14. Williams-Gray, CH, Goris, A, Saiki, M, et al. Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease. Journal of neurology. 2009;256(3):493-498.
Google Scholar | Crossref | Medline15. Monsell, SE, Besser, LM, Heller, KB, Checkoway, H, Litvan, I, Kukull, WA. Clinical and pathologic presentation in Parkinson's disease by apolipoprotein e4 allele status. Parkinsonism & related disorders. 2014;20(5):503-507.
Google Scholar | Crossref | Medline16. Hsu, M, Dedhia, M, Crusio, WE. Sex differences in gene expression patterns associated with the APOE4 allele. 2019;8:387.
Google Scholar | Crossref17. Gamache, J, Yun, Y, Chiba-Falek, O. Sex-dependent effect of APOE on Alzheimer's disease and other age-related neurodegenerative disorders. 2020;13(8):dmm045211.
Google Scholar | Crossref18. Davis, AA, Inman, CE, Wargel, ZM, et al. APOE genotype regulates pathology and disease progression in synucleinopathy. Science translational medicine. 2020;12(529):eaay3069.
Google Scholar | Crossref | Medline19. Montagne, A, Nation, DA, Sagare, AP, et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature. 2020;581(7806):71-76.
Google Scholar | Crossref | Medline20. Liu, CC, Zhao, N, Fu, Y, et al. ApoE4 Accelerates Early Seeding of Amyloid Pathology. Neuron. 2017;96(5):1024-1032.e1023.
Google Scholar | Crossref | Medline21. Kanekiyo, T, Xu, H, Bu, G. ApoE and Aβ in Alzheimer's disease: accidental encounters or partners? Neuron. 2014;81(4):740-754.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif